Cryptococcus gattii induces a cytokine pattern that is distinct from other cryptococcal species

Area of Science:

• Immunology
• Microbiology
• Infectious Diseases

Background:

• Cryptococcus species, particularly C. gattii, are emerging pathogens causing cryptococcosis.
• Understanding the host immune response is crucial for deciphering cryptococcosis pathogenesis.
• The distinct immune response to C. gattii in immunocompetent hosts requires further investigation.

Purpose of the Study:

• To compare the innate cytokine profiles induced by different Cryptococcus species in human peripheral blood mononuclear cells (PBMCs).
• To investigate the role of Toll-like receptors (TLRs) 2, 4, and 9 in the immune response to C. gattii.
• To determine if clinical C. gattii isolates elicit a different response compared to environmental isolates.

Main Methods:

• In vitro stimulation of human PBMCs from healthy individuals with heat-killed isolates of C. gattii, C. neoformans, and hybrid strains.
• Cytokine profiling using multiplex assays to measure concentrations of IL-1β, TNF-α, IL-6, IL-17, and IL-22.
• Investigating the involvement of TLR2, TLR4, and TLR9 through specific blocking or stimulation assays.

Main Results:

• C. gattii isolates induced significantly higher levels of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6) and Th17/22 cytokines (IL-17, IL-22) compared to C. neoformans.
• Clinical C. gattii isolates elicited a stronger cytokine response than environmental C. gattii isolates.
• TLR4 and TLR9 signaling pathways were implicated in the host's cytokine response to C. gattii, while TLR2 did not play a significant role.

Conclusions:

• Clinical C. gattii isolates induce a more pronounced inflammatory cytokine response in human PBMCs than other Cryptococcus species.
• This enhanced immune response to C. gattii is mediated, in part, through TLR4 and TLR9.
• The findings highlight distinct host-pathogen interactions relevant to C. gattii pathogenesis.